Yu Deng

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 04, 2020
CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.

Yu Deng, Wanjun Guo, Ning Xu

|Aug 15, 2018
Microbial Diversity of Chronic Wound and Successful Management of Traditional Chinese Medicine.

Minfeng Wu, Yan Li, Dongjie Guo

|Mar 04, 2018
Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition.

Yu Deng, Fulun Li, Pinglin He

Pageof 1